Scientific Communications: pathophysiology 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.01 - ACUTE MANAGEMENT - Neither thrombolysis nor thrombectomy O - ESOC25-1367 EFFECT OF CEREBROLYSIN ON CIRCULATING TIGHT JUNCTION PROTEINS AFTER REPERFUSION THERAPY Sawomir Michalak 1 , Jacek Namysl 2 , Krystyna Osztynowicz 3 , Joanna Rybacka-Mossakowska 2 1 Poznan University of Medical Sciences, Department of Neurochemistry and Neuropathology, Stroke Unit University Hospital Poznan, Poznan, Poland, 2 Poznan University of Medical Sciences, Stroke Unit University Hospital Poznan, Poznan, Poland, 3 Poznan University of Medical Sciences, Poznan, Poland Background and Aims: Experimental studies revealed that Cerebrolysin affects the integrity of the blood-brain barrier (BBB)
Cysteamine (Lynovex), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis
Product Details Product Name: Deadpool Blend (BPC-157/TB4/Cartalax) 10MG/10MG/10MG Form: Lyophilized powder Purity: 98% (HPLC verified) Packaging: Sterile sealed vial Storage: Store in a cool, dry place Intended Use: For laboratory research use only Notice: This material is supplied strictly for research purposes only
The targets of curcumin
We extended those findings by showing that continuous stimulation of the dentate nucleus produces sustained, frequency-dependent modulation of cortical excitability in both nave and post-stroke rodents [118, 119]
KPV is not an FDA-approved drug
